With incomplete data to guide aducanumab (Aduhelm) prescribing, neurologists face ethical challenges and will be guided best by established principles to counsel people with Alzheimer’s…
MedicallyPrime.Com
COVID-19 booster shots generated immune responses in cancer patients who had no detectable antibodies after primary vaccination, researchers said. Among seronegative patients, a third dose…
As part of MedPage Today‘s occasional series on healthcare clinicians running for office, Washington Editor Joyce Frieden spoke via phone with Rich McCormick, MD, MBA,…
Inaccuracies and falsehoods about COVID-19 continue to spread, with healthcare providers contributing to the confusion. The National Council of State Boards of Nursing (NCSBN) announced…
In the 12-month period ending in April, more than 100,000 people in the U.S. died from drug overdoses — the most recorded in a year-long…
The investigational long-acting amylin analogue cagrilintide (AM833) helped people with overweight or obesity, but no diabetes, shed pounds in a phase II trial. In the…
MedPage Today asked several doctors and public health experts to share their holiday plans in light of the current COVID-19 situation in the U.S. With…
Almost a third of caregivers for childhood cancer survivors were reluctant to have the youngsters vaccinated against COVID-19. (Duke Health, Pediatric Blood & Cancer) A…
Among patients who underwent a hysterectomy for benign indications, a later surgical start time lengthened hospital stay and increased blood loss, according to a retrospective…
The FDA approved pembrolizumab (Keytruda) for the adjuvant treatment of renal cell carcinoma (RCC) for patients who have an intermediate-high or high risk of recurrence…